Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed CMEA Ventures Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
CMEA Ventures is a San Francisco based venture capital firm that specializes in high technology, life sciences, and alternative energy investments. The firm invests in both early and late stage companies, and actively partners with its extended network of companies, other VC firms, institutional investors, strategic partners as well as entrepreneurs. CMEA was originally formed as an affiliate of New Enterprise Associates (NEA) in 1989 and became independent in 1997. CMEA currently has 74 portfolio companies, 6 funds and manages $1.2 billion of venture capital.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2014 | Odyssey Logistics &a; Technology Corporation | Venture Round | 40M |
| 1/2014 | Odyssey Logistics &a; Technology Corporation | Venture Round | 48M |
| 1/2005 | Predix Pharmaceuticals | Series C | 0 |
| 8/2003 | Myogen | Series D | 40M |
| 6/2008 | VeraLight | Series C | 0 |
| 8/2004 | Kalypsys | Series B | 29M |
| 1/2001 | Salmedix | Series A | - |
| 10/2003 | RF Magic | Series C | 0 |
| 9/2003 | Odyssey Logistics &a; Technology Corporation | Series A | 24.3M |
| 11/2007 | Ensemble Discovery | Series B | 15M |
| 1/2003 | Raven Biotechnologies | Series C | 0 |
| 9/2002 | Alexza Pharmaceuticals | Series A | 0 |
| 1/2006 | Solyndra | Series B | 79.2M |
| 9/2007 | Odyssey Logistics &a; Technology Corporation | Series C | 5M |
| 12/2010 | Odyssey Logistics &a; Technology Corporation | Venture Round | 20M |
| 2/2005 | Odyssey Logistics &a; Technology Corporation | Series B | 11M |
| 10/2001 | Altus Pharmaceuticals | Series B | 50.8M |
| 4/2002 | Dassault Systemes | Venture Round | 14.1M |
| 4/2007 | Superprotonic | Series B | 16.2M |
| 11/2006 | Tetraphase Pharmaceuticals | Series A | 10M |
| 10/2006 | VeraLight | Series B | 0 |
| 5/2005 | Bayhill Therapeutics | Series B | 35.4M |
| 9/2009 | Tetraphase Pharmaceuticals | Series B | 0 |
| 1/2004 | Bayhill Therapeutics | Series A | - |
| 8/2000 | E-Markets | Series B | 10M |
| 11/2004 | Mojo Networks | Series A | 10.3M |
| 7/2007 | Telsima | Debt Financing | 25M |
| 6/2003 | Phenomix | Series A | 11.6M |
| 8/2007 | MailExpress | Series B | 15M |
| 1/2006 | Entropic | Series C | 0 |
| 2/2002 | PathScale | Series A | 1.5M |
| 5/2004 | PathScale | Series C | 15M |
| 11/2006 | Dassault Systemes | Venture Round | - |
| 11/2004 | BioMimetic Therapeutics | Series C | 25.7M |
| 2/2003 | PathScale | Series B | 12.5M |
| 7/2004 | Phenomix | Series A | 2M |
| 7/2000 | Alliance Fiber Optic Products | Venture Round | 27.5M |
| 7/2003 | Sanera Systems | Series C | 35M |
| 2/2008 | Pyxis Technology | Series B | 5.3M |
| 3/2002 | Phenomix | Series A | 12M |
| 3/2002 | Siros Technologies | Venture Round | 17M |
| 8/2001 | Myogen | Series D | 52.4M |
| 1/2001 | Ensim Corporation | Venture Round | 0 |
| 1/2005 | Alexza Pharmaceuticals | Series D | 0 |
| 4/2006 | Bayhill Therapeutics | Venture Round | 15.8M |
| 1/2003 | Perlegen Sciences | Series C | 30M |
| 3/2009 | Draths Corporation | Series C | 7.8M |
| 2/2000 | ChemConnect | Private Equity Round | 0 |
| 11/2001 | iSuppli | Series C | - |
| 11/2000 | iSuppli | Series B | 30M |
| 8/2003 | CPlane | Series D | 2.5M |
| 7/2002 | AWR Corporation | Series B | 7.4M |
| 10/2008 | Arcadia Biosciences | Private Equity Round | 15M |
| 5/2004 | Altus Pharmaceuticals | Series C | 0 |
| 11/2005 | Pyxis Technology | Series A | 250k |
| 5/2008 | NovX | Series C | 0 |
| 4/2005 | Phenomix | Series B | 20M |
| 6/2010 | Solyndra | Private Equity Round | 175M |
| 3/2005 | NovX | Series B | 6.4M |
| 1/2001 | CPlane | Series C | 25M |
| 2/2000 | Xenoport | Series A | 15.9M |
| 5/2005 | BioMimetic Therapeutics | Series C | 11.8M |
| 5/2005 | Symwave | Series B | 6.1M |
| 12/2007 | Arcion Therapeutics | Series A | 8.8M |
| 6/2002 | Salmedix | Series B | 27.5M |
| 2/2007 | Visiogen | Venture Round | 24M |
| 7/2011 | SurgiQuest | Series C | 19M |
| 8/2007 | NovX | Debt Financing | 0 |
| 10/2008 | InSound Medical | Series E | 13M |
| 2/2004 | Inovys | Series C | 0 |
| 9/2014 | Odyssey Logistics &a; Technology Corporation | Venture Round | 0 |
| 1/2014 | Odyssey Logistics &a; Technology Corporation | Venture Round | 0 |
| 7/2011 | SurgiQuest | Series C | 0 |
| 12/2010 | Odyssey Logistics &a; Technology Corporation | Venture Round | 0 |
| 6/2010 | Solyndra | Private Equity Round | 0 |
| 9/2009 | Tetraphase Pharmaceuticals | Series B | 0 |
| 3/2009 | Draths Corporation | Series C | 0 |
| 10/2008 | Arcadia Biosciences | Private Equity Round | 0 |
| 10/2008 | InSound Medical | Series E | 0 |
| 6/2008 | VeraLight | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
